---
title: "SKYWORTH GROUP has suspended trading this morning due to merger and acquisition and repurchase news"
description: "SKYWORTH GROUP Co., Ltd. has temporarily suspended trading since 9 AM today (5th) to await the announcement containing insider information in accordance with the company's acquisition, merger, and sha"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/271447324.md"
published_at: "2026-01-05T01:42:24.000Z"
---

# SKYWORTH GROUP has suspended trading this morning due to merger and acquisition and repurchase news

> SKYWORTH GROUP Co., Ltd. has temporarily suspended trading since 9 AM today (5th) to await the announcement containing insider information in accordance with the company's acquisition, merger, and share repurchase regulations

SKYWORTH GROUP (00751.HK) shares have been temporarily suspended from trading since 9 AM today (5th) pending the issuance of an announcement containing inside information in accordance with the company's rules on acquisitions, mergers, and share repurchases

### Related Stocks

- [00751.HK - SKYWORTH GROUP](https://longbridge.com/en/quote/00751.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| 00:16 ETSKYWORTH PV neemt deel aan Expo Greater Amsterdam met zijn SUN Mate-balkonzonnepaneeloplossing | SKYWORTH PV will participate in Expo Greater Amsterdam from March 10-12, 2026, showcasing its SUN Mate balcony solar pan | [Link](https://longbridge.com/en/news/275995515.md) |
| Skyworth Group Limited's (HKG:751) Top Key Executive Wang Wong is the most upbeat insider, and their holdings increased by 37% last week | Skyworth Group Limited's largest shareholder, Wang Wong, increased his holdings by 37% last week, reflecting significant | [Link](https://longbridge.com/en/news/273567949.md) |
| Nomura Upgrades China Literature to Buy From Neutral, Adjusts Price Target to HK$47 From HK$33 | Nomura Upgrades China Literature to Buy From Neutral, Adjusts Price Target to HK$47 From HK$33 | [Link](https://longbridge.com/en/news/275882954.md) |
| Sino Biopharm Wins China Nod for New Lung Cancer Use of PD-L1 Drug | Sino Biopharmaceutical has received Chinese regulatory approval for its PD-L1 inhibitor, benmelstobart, for use as maint | [Link](https://longbridge.com/en/news/276016059.md) |
| China’s Lenovo warns of ‘prolonged’ memory crunch, looks to AI for rebound | Lenovo Group, the largest PC maker, reported a 21% profit drop due to a global memory crunch, warning of its prolonged i | [Link](https://longbridge.com/en/news/275760673.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.